Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Concordia University

$24,000.00

Optimizing Mass Spectrometry Imaging for Next Generation Pharmaceutical Research

EF 2021-22

Résumé
Imaging mass spectrometry (IMS) is a label-free molecular imaging technique with emerging applications in clinical research. There are two IMS methods with cellular spatial resolution, secondary ion mass spectrometry (SIMS) and matrix assistant laser desorption ionization (MALDI) using ion beams and laser, respectively, to capture molecular snapshots of biological materials. These complementary techniques have unique advantages and different challenges. For example, sub-micron laterally resolved ion images are common in SIMS imaging owing to the nature of the ion beam and advance ion beam focusing techniques, however, the harsh bombardment of the projectile limits molecular ion yields. Together MALDI and SIMS imaging fill the analytical performance gaps for label-free biomolecular imaging and produce a comprehensive picture of the proteins, lipids, and metabolites in tissue. The research program will focus on improving the ion image quality (i.e. molecular sensitivity, quantification ability, and lateral resolution measurements) and establishing synergistic workflows that combine SIMS and MALDI IMS. The protocols and methodologies established in the research program will provide a basis for characterizing and improving ion image quality. The collective outcome of the research program will ensure progress towards the acceptance of IMS technology in clinical histopathology and clinical pharmacology by improving the detection of biomolecule and pharmaceutical compounds in tissue and cells.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2021-04153
Name nom
Passarelli, Melissa
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
24000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
515
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Instrumentation technology
Area of application fr
Technologie de l'instrumentation
Research subject code
3500
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Analytical chemistry
Research subject fr
Chimie analytique
Installment
inst:1
Partie
1
Nb partie
5
Application title
Optimizing Mass Spectrometry Imaging for Next Generation Pharmaceutical Research
Keyword
NSERC
Application summary
Imaging mass spectrometry (IMS) is a label-free molecular imaging technique with emerging applications in clinical research. There are two IMS methods with cellular spatial resolution, secondary ion mass spectrometry (SIMS) and matrix assistant laser desorption ionization (MALDI) using ion beams and laser, respectively, to capture molecular snapshots of biological materials. These complementary techniques have unique advantages and different challenges. For example, sub-micron laterally resolved ion images are common in SIMS imaging owing to the nature of the ion beam and advance ion beam focusing techniques, however, the harsh bombardment of the projectile limits molecular ion yields. Together MALDI and SIMS imaging fill the analytical performance gaps for label-free biomolecular imaging and produce a comprehensive picture of the proteins, lipids, and metabolites in tissue. The research program will focus on improving the ion image quality (i.e. molecular sensitivity, quantification ability, and lateral resolution measurements) and establishing synergistic workflows that combine SIMS and MALDI IMS. The protocols and methodologies established in the research program will provide a basis for characterizing and improving ion image quality. The collective outcome of the research program will ensure progress towards the acceptance of IMS technology in clinical histopathology and clinical pharmacology by improving the detection of biomolecule and pharmaceutical compounds in tissue and cells.